Diastat and Keratosis - seborrheic - a phase IV clinical study of FDA data
We study 1,799 people who take Diastat or have Keratosis - seborrheic. No report of Keratosis - seborrheic is found in people who take Diastat.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Diastat?
Diastat has active ingredients of diazepam. eHealthMe is studying from 1,791 Diastat users for its effectiveness, alternative drugs and more.
What is Keratosis - Seborrheic?
Keratosis - seborrheic: no further information found.
Do you take Diastat and have Keratosis - seborrheic?Check whether Keratosis - seborrheic is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Keratosis - seborrheic and when was it recovered:
Expand to all the drugs that have ingredients of diazepam:
Alternative drugs to, pros and cons of Diastat:
- Diastat (1,791 reports)
Keratosis - seborrheic treatments and more:
- Keratosis - seborrheic (8 reports)
COVID vaccines that are related to Keratosis - seborrheic:
- Keratosis - seborrheic in Moderna COVID Vaccine
- Keratosis - seborrheic in Pfizer BioNTech Covid Vaccine
- Keratosis - seborrheic in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Keratosis - seborrheic:
All the conditions that are associated with Keratosis - seborrheic:
How the study uses the data?
The study uses data from the FDA. It is based on diazepam (the active ingredients of Diastat) and Diastat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Capecitabine and Lymph Follicular Hypertrophy - now
- Ativan and Skin Ulcer - 12 seconds ago
- Hydrochlorothiazide and Condylox drug interaction - 15 seconds ago
- Starlix and Benicar drug interaction - 15 seconds ago
- Hepatitis Alcoholic and pfizer biontech covid vaccine - 15 seconds ago
- Magnesium and Dactylitis - 18 seconds ago
- Prialt and Bone Decalcification - 18 seconds ago
- Nucynta and Erection Problems - 20 seconds ago
- Premarin and Plan B drug interaction - 22 seconds ago
- Anaesthesia and Congestive Cardiomyopathy - 23 seconds ago